Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
How to avoid or deal with an outrageous medical bill - 24 well known subjects in school
- 3Cuba says 33 have died of mosquito-borne illnesses as epidemic rages
- 44 Sound blocking Earphones for Prevalent Sound and Solace
- 5‘Integral part of our nation’: Herzog visits Franciscan Sisters in Jerusalem ahead of Christmas
- Excelling at Cash The board: A Manual for Monetary Essentials
- Investigate These Retreats Well known With Seniors
- Zelensky confidant dismissed from further posts amid bribery scandal
- Mali and Canadian miner Barrick agree to resolve tax dispute, ending 2-year standoff
- Dominating the Mastercard Endorsement Cycle: Six Fundamental Stages
- Really focusing on Succulents: Tips and Procedures
- Family Holiday spots
- IDF destroys two-kilometer-long Gaza terror tunnel in Beit Lahiya
- Step by step instructions to Open a Lovely Waterway Voyage Insight: Conveniences, Administrations, and Elite Offers
